Health and Fitness Health and Fitness
Fri, July 23, 2010
[ 11:33 AM ] - Market Wire
Teva Comments on Generic Lovenox® Approval
[ 07:57 AM ] - Market Wire
Psychiatric Solutions Announces Date for Second Quarter 2010 Earnings Release
[ 06:59 AM ] - Market Wire
IntegraMed® Adds Austin Fertility Institute to its Attain Fertility Centers Network
[ 06:00 AM ] - Market Wire
ABRAXANE® Approved for Marketing in Japan for Breast Cancer
[ 05:30 AM ] - Market Wire
XenoPort Announces Presentation of Preclinical Da .. mprosate Prodrug at Fragile X Syndrome Conference
Thu, July 22, 2010
[ 02:19 PM ] - Market Wire
NOVT Corporation Completes Reverse/Forward Stock Split
[ 02:00 PM ] - Market Wire
Kindred Healthcare Announces 32 Recipients of National Quality Awards
[ 02:00 PM ] - Market Wire
Genzyme Corporation, Shire plc, Protalix BioTherapeutics, Hospira Worldwide and Apache
[ 01:30 PM ] - Market Wire
Impax Laboratories Receives Final FDA Approval for Generic OPANA® ER Tablets
[ 01:27 PM ] - Market Wire
PerkinElmer to Hold Earnings Call on Thursday, August 5, 2010
[ 01:05 PM ] - Market Wire
Vascular Solutions Announces Record Second Quarte .. sults; Net Revenue Increases 14% to $19.5 Million
[ 01:01 PM ] - Market Wire
Human Genome Sciences Announces Second Quarter 2010 Financial Results and Key Developments
[ 12:23 PM ] - Market Wire
AGA Medical to Host Second Quarter EarningsConference Call on Tuesday, Aug. 3, 2010
[ 11:00 AM ] - Market Wire
Atrium Innovations to Hold 2010 Second Quarter Fi .. esults Conference Call and Webcast on August 13th
[ 09:00 AM ] - Market Wire
Bristol-Myers Squibb National Survey Finds a Disp .. oviders and HIV Positive Patients Perspectives on
[ 08:00 AM ] - Market Wire
LifePoint Hospitals to Broadcast Its Second Quarter 2010 Conference Call Live on the Internet
[ 07:00 AM ] - Market Wire
Orthovita to Present at the Canaccord Genuity 30th Annual Growth Conference
[ 06:25 AM ] - Market Wire
Novelos Therapeutics Announces $1.5 Million Registered Direct Offering
[ 06:00 AM ] - Market Wire
Alliance HealthCare Services Schedules Conference .. t to Review Second Quarter 2010 Financial Results
[ 06:00 AM ] - Market Wire
Ligand to Report Second Quarter Results on August 5th
[ 05:30 AM ] - Market Wire
CytRxa?s Tamibarotene Eradicates Cancer in Advanc .. locytic Leukemia After Failure of Other Therapies
[ 05:30 AM ] - Market Wire
St. Jude Medical Reports Second Quarter 2010 Results
[ 05:00 AM ] - Market Wire
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KGaA Settle NAMENDA® Patent Litigation
[ 05:00 AM ] - Market Wire
International Stem Cell Plans $10 Million Financing Through European Subsidiary
[ 04:30 AM ] - Market Wire
POZEN To Present at The BMO Capital Markets Focus on Healthcare Conference
[ 04:12 AM ] - Market Wire
Dr. Reddya?s Q1 FY11 Financial Results
[ 04:03 AM ] - Market Wire
Laboratory Corporation of America® Holdings Announces 2010 Second Quarter Results
[ 04:01 AM ] - Market Wire
GenMark Diagnostics Schedules Second Quarter Earn .. gs Release and Conference Call for August 9, 2010
[ 04:00 AM ] - Market Wire
Natus Medical to Hold 2010 Second Quarter Financial Results Conference Call on July 29
[ 04:00 AM ] - Market Wire
Antigenics to Report Second Quarter Financial Results on July 29, 2010; Conference Call to Follow

Antigenics to Report Second Quarter Financial Results on July 29, 2010; Conference Call to Follow


Published on 2010-07-22 04:06:17 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--Antigenics Inc. (NASDAQ: AGEN) will release its second quarter financial results before the market opens on July 29, 2010.

Antigenics executives will host a conference call at 11:00 a.m. Eastern Time that same day. To access the live call, dial 877.762.5772 (domestic) or 706.643.6986 (international); the access code is 87992038. The call will also be webcast and will be accessible from the companya™s website at [ www.antigenics.com/webcast/ ]. A replay will be available approximately two hours after the call through midnight Eastern Time on January 29, 2011. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 87992038. The replay will also be available on the companya™s website approximately two hours after the live call.

Antigenics is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit [ www.antigenics.com ].

Contributing Sources